Latest News | Jan 9, 2022

The 2021 Year in Review in Prescription Drug Pricing

Drug pricing was trending in 2021. Here’s a look back at patient advocacy wins and progress toward victories in the year to come.

Welcome to the Year in Review.

1. One-On-Ones With The White House

2. Fighting Pharma’s Falsehoods

3. Congressional Priority: Drug Pricing

4. Patients Fired Up

5. Thank You, Taxpayers

2020, what a year it has been. We welcome 2021 and wish health, hope, and happiness to you all.

1. Candidates’ Campaign Promises

2. Taxpayer-Funded Light At The End Of The Tunnel

3. Big Pharma’s Lies Spectacularly Revealed

4. Business As Usual

5. Patients Speak, Work Toward Change

Goodbye, 2019. Hello, 2020! Here is a look at the year in review in prescription drug pricing:

1. States Take a Stand

2. Federal Momentum Grows

3. Patient Voices Grow Louder 

4. Pharma Loses Its Edge

5. It’s Not Perfect, But It’s Progress

It’s a new year and drug pricing reform is here to stay. Here are our top 5 takeaways from 2018:
1. Patient Voices Grew Louder — Drugs Don’t Work If People Can’t Afford Them.

2. Patient Influence Expanded in Washington, DC

3. States Took A Stand

4. From the Kitchen Table to the Ballot Box

5. The Blinding Glare of Patient Scrutiny

Happy 2019. Cheers to a fruitful year of drug pricing reform!
— The Team at Patients For Affordable Drugs Now.